| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2295539A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 01/21/1999 | CA2295375A1 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 01/21/1999 | CA2295218A1 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
| 01/21/1999 | CA2295086A1 Wa545 compositions |
| 01/21/1999 | CA2294732A1 Ctl epitopes from ebv |
| 01/21/1999 | CA2292843A1 Reagents and methods useful for detecting diseases of the breast |
| 01/21/1999 | CA2290716A1 Fusion proteins comprising coiled-coil structures |
| 01/20/1999 | EP0892064A2 Recombinant secA2 polypeptide from Staphylococcus aureus and uses thereof |
| 01/20/1999 | EP0892063A2 Histidine kinase |
| 01/20/1999 | EP0892062A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC |
| 01/20/1999 | EP0892060A2 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratA |
| 01/20/1999 | EP0892059A2 Histidine kinase polypeptides |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892056A2 GidA1 polypeptides from Chlamydia trachomitis |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892050A2 Human HFIZG53 |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0892047A2 Human and murine semaphorin L |
| 01/20/1999 | EP0892046A2 Melatonin-receptor expression cells and their uses |
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891983A1 Novel tarF |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891549A2 Foetal cell analysis |
| 01/20/1999 | EP0891428A1 Phosphatidylinositol 3-kinase p110 delta catalytic subunit |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891364A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines |
| 01/20/1999 | EP0656908B1 Use of specific binding molecules in potentiating igf-i activity |
| 01/20/1999 | EP0597960B1 Treatment of cell populations |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205740A Diagnosis and treatment of Aur-1 and/or Aur-2 related disorders |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205642A Sugar chain-recognizing antibody and remedy for infection with HIV |
| 01/19/1999 | US5861499 Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861496 Nucleic acid and amino acid sequences of a novel squalene epoxidase and to the use of these sequences in the diagnosis, prevention, and treatment of diseases such as hypercholesterolemia and atherosclerosis. |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861310 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
| 01/19/1999 | US5861281 Lacc |
| 01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
| 01/19/1999 | US5861266 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 01/19/1999 | US5861264 Determination presence of autoantibodies against mast cell specific proteins such as tryptase and chymase |
| 01/19/1999 | US5861262 Method of the specific immunoassay of human plasma glutathione peroxidase, kit for its implementation, oligopeptides and antibodies specific for the method |
| 01/19/1999 | US5861260 Contacting sample from patient with a pure centrosomal protein cp140 polypeptide fragment so that it will bind to autoantibodies, detecting autoantibody:cp140 complexes, if present, indicates disease |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861258 Use of the alpha interferon receptor and cells which express the receptor, for identification of alpha interferon agonists |
| 01/19/1999 | US5861257 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 01/19/1999 | US5861243 Amino acid sequences |
| 01/19/1999 | US5861241 Monoclonal antibodies for detecting Norwalk virus |
| 01/19/1999 | US5861163 Immunnology and cells |
| 01/19/1999 | US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | US5861155 Humanized antibodies and uses thereof |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/18/1999 | CA2237160A1 Gida1 |
| 01/18/1999 | CA2237143A1 Novel rata |
| 01/18/1999 | CA2237140A1 Novel tarf |
| 01/18/1999 | CA2237050A1 Histidine kinase |
| 01/18/1999 | CA2237043A1 Response regulator |
| 01/16/1999 | CA2237784A1 Novel compounds |
| 01/15/1999 | CA2220849A1 A human pelota homolog |
| 01/14/1999 | WO1999001767A1 Reagent for detecting and monitoring viral infections |
| 01/14/1999 | WO1999001764A2 METHOD FOR DETERMINING GnRH RECEPTORS |
| 01/14/1999 | WO1999001560A1 Vertebrate telomerase genes and proteins and uses thereof |
| 01/14/1999 | WO1999001556A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 01/14/1999 | WO1999001554A1 Mammalian secretory peptide-9 |
| 01/14/1999 | WO1999001553A1 Murine and human cerberus-like proteins and compositions comprising them |
| 01/14/1999 | WO1999001477A1 Method for diagnosing systemic lupus erythematosus |
| 01/14/1999 | WO1999001476A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
| 01/14/1999 | WO1999001475A2 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines |
| 01/14/1999 | WO1999001020A2 19 human secreted proteins |
| 01/14/1999 | WO1998050555A3 Enterococcus faecalis polynucleotides and polypeptides |
| 01/14/1999 | WO1998050431A3 A method for making multispecific antibodies having heteromultimeric and common components |
| 01/14/1999 | WO1998049314A3 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 01/14/1999 | WO1998038212A3 Chimeric polypeptides containing chemokine domains |
| 01/14/1999 | WO1998021333A3 Nucleic acid encoding schwannomin-binding-proteins and products related thereto |
| 01/14/1999 | DE19729544A1 Ancrod spezifische monoklonale Antikörper, Antikörperfragmente, deren Mischung oder Derivate und deren Verwendung Ancrod specific monoclonal antibodies, antibody fragments, their mixture or their derivatives and the use thereof |
| 01/14/1999 | CA2295962A1 Reagent for detecting and monitoring viral infections |
| 01/14/1999 | CA2294833A1 Crystal structures of anti-factor ix fab fragments and methods of use for peptidomimetic design |
| 01/14/1999 | CA2294782A1 Vertebrate telomerase genes and proteins and uses thereof |
| 01/14/1999 | CA2294705A1 19 human secreted proteins |
| 01/14/1999 | CA2294702A1 Mammalian secretory peptide-9 |
| 01/14/1999 | CA2236489A1 Novel compounds |
| 01/13/1999 | EP0890840A2 Assaying for collagen degradation in vivo |
| 01/13/1999 | EP0890647A2 PcrA, novel polypeptide of the DNA helicases family |
| 01/13/1999 | EP0890644A2 MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase |
| 01/13/1999 | EP0890643A2 25-Hydroxyvitamin D3-1a-hydroxylase and dna encoding the hydroxylase |
| 01/13/1999 | EP0890641A1 Novel IspA |
| 01/13/1999 | EP0889964A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/13/1999 | EP0889963A1 Nucleic acid molecules encoding cytochrome p450-type proteins involved in the brassinosteroid synthesis in plants |
| 01/13/1999 | EP0889961A2 Monocyte chemotactic protein-5 materials and methods |